Home PR Newswire
Wednesday, June 24, 2026
24.4
C
Bengaluru
Hot topics
Quality, Not Price: Why the Generic Drug Debate Keeps Missing the Point
In an earlier article in The Wire Science, I...
Mounjaro Upends Semaglutide Gold Rush: IPM May 2026
1. The Eli Lilly & Mounjaro Disruption: A New...
IMS Health Market Reflection Report for August 2016
The Indian Pharmaceutical Market (IPM) was valued at Rs. 10,426 crores in the month of August 2016 clocking a strong 18% growth over same period last year (SPLY). This was the second consecutive month where the IPM crossed the 10,000 crore mark.
Indian Pharma: Are Regulatory Gaps From Generics Following Biosimilars?
Transparency, Trust, and the Problem of “Invisible Evidence” in...
Is Your Field Force Optimised to Make the Most of Market Growth in Metros?
Summary of Performance of Top 30 Metros in IPM...
The Data Graveyard: Why India’s Private Hospitals Fail at Medical Research
The Data Graveyard: Why India’s Private Hospitals Fail at...
What Leadership is Not! Position, Authority, or Activity
Leadership is not Measured by Position, Authority, or Activity.
It...
Navigating the Jungle: How to Turn Field Chaos Into Your Brand’s Competitive Advantage
To navigate chaos, you first need to know who...
Cipla appoints Shivam Puri as CEO of One India Business
Shivam Puri has been appointed Chief Executive Officer of...
Mounjaro Upends Semaglutide Gold Rush: IPM May 2026
1. The Eli Lilly & Mounjaro Disruption: A New...
The Data Graveyard: Why India’s Private Hospitals Fail at Medical Research
The Data Graveyard: Why India’s Private Hospitals Fail at...
What Leadership is Not! Position, Authority, or Activity
Leadership is not Measured by Position, Authority, or Activity.
It...
Navigating the Jungle: How to Turn Field Chaos Into Your Brand’s Competitive Advantage
To navigate chaos, you first need to know who...
Cipla appoints Shivam Puri as CEO of One India Business
Shivam Puri has been appointed Chief Executive Officer of...
Mounjaro Upends Semaglutide Gold Rush: IPM May 2026
1. The Eli Lilly & Mounjaro Disruption: A New...
The Data Graveyard: Why India’s Private Hospitals Fail at Medical Research
The Data Graveyard: Why India’s Private Hospitals Fail at...
What Leadership is Not! Position, Authority, or Activity
Leadership is not Measured by Position, Authority, or Activity.
It...
Navigating the Jungle: How to Turn Field Chaos Into Your Brand’s Competitive Advantage
To navigate chaos, you first need to know who...
Cipla appoints Shivam Puri as CEO of One India Business
Shivam Puri has been appointed Chief Executive Officer of...
Mounjaro Upends Semaglutide Gold Rush: IPM May 2026
1. The Eli Lilly & Mounjaro Disruption: A New...
The Data Graveyard: Why India’s Private Hospitals Fail at Medical Research
The Data Graveyard: Why India’s Private Hospitals Fail at...
What Leadership is Not! Position, Authority, or Activity
Leadership is not Measured by Position, Authority, or Activity.
It...
Navigating the Jungle: How to Turn Field Chaos Into Your Brand’s Competitive Advantage
To navigate chaos, you first need to know who...
Cipla appoints Shivam Puri as CEO of One India Business
Shivam Puri has been appointed Chief Executive Officer of...
Mounjaro Upends Semaglutide Gold Rush: IPM May 2026
1. The Eli Lilly & Mounjaro Disruption: A New...
Hot topics
Has Indian Pharma Seen The Longevity Tsunami Coming?
Why India Must Urgently Reinvent Healthcare for a 100-Year...
Indian Pharma: Are Regulatory Gaps From Generics Following Biosimilars?
Transparency, Trust, and the Problem of “Invisible Evidence” in...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Healthcare and Gulf War: When Elephants Fight, the Grass Gets Trampled
From Gas Cylinders to ICU Beds: How the Gulf...
The Data Graveyard: Why India’s Private Hospitals Fail at Medical Research
The Data Graveyard: Why India’s Private Hospitals Fail at...
What Leadership is Not! Position, Authority, or Activity
Leadership is not Measured by Position, Authority, or Activity.
It...
Navigating the Jungle: How to Turn Field Chaos Into Your Brand’s Competitive Advantage
To navigate chaos, you first need to know who...
Cipla appoints Shivam Puri as CEO of One India Business
Shivam Puri has been appointed Chief Executive Officer of...
Mounjaro Upends Semaglutide Gold Rush: IPM May 2026
1. The Eli Lilly & Mounjaro Disruption: A New...
The Data Graveyard: Why India’s Private Hospitals Fail at Medical Research
The Data Graveyard: Why India’s Private Hospitals Fail at...
What Leadership is Not! Position, Authority, or Activity
Leadership is not Measured by Position, Authority, or Activity.
It...
Navigating the Jungle: How to Turn Field Chaos Into Your Brand’s Competitive Advantage
To navigate chaos, you first need to know who...
Cipla appoints Shivam Puri as CEO of One India Business
Shivam Puri has been appointed Chief Executive Officer of...
Mounjaro Upends Semaglutide Gold Rush: IPM May 2026
1. The Eli Lilly & Mounjaro Disruption: A New...
The Data Graveyard: Why India’s Private Hospitals Fail at Medical Research
The Data Graveyard: Why India’s Private Hospitals Fail at...
What Leadership is Not! Position, Authority, or Activity
Leadership is not Measured by Position, Authority, or Activity.
It...
Navigating the Jungle: How to Turn Field Chaos Into Your Brand’s Competitive Advantage
To navigate chaos, you first need to know who...
Cipla appoints Shivam Puri as CEO of One India Business
Shivam Puri has been appointed Chief Executive Officer of...
Mounjaro Upends Semaglutide Gold Rush: IPM May 2026
1. The Eli Lilly & Mounjaro Disruption: A New...
The Data Graveyard: Why India’s Private Hospitals Fail at Medical Research
The Data Graveyard: Why India’s Private Hospitals Fail at...
What Leadership is Not! Position, Authority, or Activity
Leadership is not Measured by Position, Authority, or Activity.
It...
Navigating the Jungle: How to Turn Field Chaos Into Your Brand’s Competitive Advantage
To navigate chaos, you first need to know who...
Cipla appoints Shivam Puri as CEO of One India Business
Shivam Puri has been appointed Chief Executive Officer of...
Mounjaro Upends Semaglutide Gold Rush: IPM May 2026
1. The Eli Lilly & Mounjaro Disruption: A New...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
The Data Graveyard: Why India’s Private Hospitals Fail at Medical Research
The Data Graveyard: Why India’s Private Hospitals Fail at...
What Leadership is Not! Position, Authority, or Activity
Leadership is not Measured by Position, Authority, or Activity.
It...
Navigating the Jungle: How to Turn Field Chaos Into Your Brand’s Competitive Advantage
To navigate chaos, you first need to know who...
Cipla appoints Shivam Puri as CEO of One India Business
Shivam Puri has been appointed Chief Executive Officer of...
Newsletter
Get important news delivered directly to your inbox and stay connected!